At meeting held on 28 April 2022
The Board of Ami Organics at its meeting held on 28 April 2022 has approved the capex plan for Ankleshwar unit as under:The capex plan of Ankleshwar Unit entails an outlay of Rs 190 crore to build a brownfield plant to support the future business growth of the company's advanced pharmaceutical intermediates segment. The existing structure of Ankleshwar Unit will be completely demolished and a new Plant will be built on the land. The Ankleshwar unit has received necessary environmental clearance and the new facility will have ~90 reactors taking the total reactor capacity to 436KL. The plant is expected to start commercial operations from January 2024. The Capex will be funded through a mix of General Corporate funds of IPO proceeds, internal accruals, and bank finance.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
